Member Info for draft

A farm out process is now underway which has attracted a significant level of interest and our focus now is to seek to introduce the best possible partner to progress these prospects towards drilling.

https://www.cnbc.com/2021/04/19/uk-to-explore-issuing-its-own-digital-currency-amid-bitcoin-boom.html

large buys showing up

have been deleted, pathetic, I knew id trigger some of you

https://www.telegraph.co.uk/technology/2021/04/19/darktrace-sets-may-date-3bn-london-float/

I can smell the chronic from here, must be imminent

Get to 2.5p before the next raise. So it doesn't raise at a crap price. Obviously delt will fully use up remaining cash in the next drill planned. Burn rate too high for basic operational costs in my opinion also.

Revolut’s founder Nik Storonsky is planning a fundraising that would value the money transfer app at up to $15 billion (£10.8 billion).

The company has lined up specialist fintech investment bank FT Partners to advise on an equity investment later this year, Sky News reported.

Investors in Revolut expect the funding round to give Revolut a valuation of between $10 billion and $15 billion, making Storonsky a multibillionaire in dollar terms and one of Europe’s youngest fintech billionaires. The 36-year-old attracted headlines in 2018 for saying that work-life balance would not help start-up founders trying to compete with bigger players. The new equity raise would also cement Revolut’s position as one of the UK’s most valuable technology companies. Sky reported that it could involve the sale of $250 million of new shares. Revolut, founded in 2015, was valued at $5.5 billion in early 2020 after a $500 million funding round led by US fund Technology Crossover Ventures, an early investor in Airbnb, Netflix and Spotify. TSG Consumer Partners invested $80 million in June last year.

Revolut operates in 35 countries. The app is in the process of applying for a banking licence in the UK — its home country and biggest market — and last month completed the first step in applying for a licence in the US. It has 15 million customers globally, many of whom use it for cheap foreign exchange transactions.

The app, chaired by former Aberdeen boss Martin Gilbert, is expected to announce its 2020 annual results next month.

Revolut’s founder Nik Storonsky is planning a fundraising that would value the money transfer app at up to $15 billion (£10.8 billion).

The company has lined up specialist fintech investment bank FT Partners to advise on an equity investment later this year, Sky News reported.

Investors in Revolut expect the funding round to give Revolut a valuation of between $10 billion and $15 billion, making Storonsky a multibillionaire in dollar terms and one of Europe’s youngest fintech billionaires. The 36-year-old attracted headlines in 2018 for saying that work-life balance would not help start-up founders trying to compete with bigger players. The new equity raise would also cement Revolut’s position as one of the UK’s most valuable technology companies. Sky reported that it could involve the sale of $250 million of new shares. Revolut, founded in 2015, was valued at $5.5 billion in early 2020 after a $500 million funding round led by US fund Technology Crossover Ventures, an early investor in Airbnb, Netflix and Spotify. TSG Consumer Partners invested $80 million in June last year.

Revolut operates in 35 countries. The app is in the process of applying for a banking licence in the UK — its home country and biggest market — and last month completed the first step in applying for a licence in the US. It has 15 million customers globally, many of whom use it for cheap foreign exchange transactions.

The app, chaired by former Aberdeen boss Martin Gilbert, is expected to announce its 2020 annual results next month.

Alphagreen, a European marketplace for cannabis products is launching the largest ever crowdfunding raise in the CBD and medical cannabis space.

The cash injection will be used to grow its e-commerce and digital marketing operations, andexpand into new global territories.

Retail investors can register their interest in buying into the London-based start-up via the Seedrs equity crowdfunding platform. Existing investors include Stockholm-based Enexis AB, US cannabis fund West Creek Investments and angel investors, including Igor and Oleg Tikhturov.

Co-founder and CEO of Alphagreen, Alexej Pikovsky, said: “The cannabis industry is here to stay. The global market is poised for a significant growth phase and Alphagreen is perfectly positioned to capitalise on the increased use of medicinal cannabis and fundamental changes to the way the cannabis and CBD market will function.” CBD platform Alphagreen raises £1m-plus before funding push goes public

already raised about 2mill

StockBible
@StockBible
·
2h
Uk gas prices smashing it. #DELT have £12m cash, no debt and £25m market cap. When you look at the farm out carry of $10m on Pensacola 3D and 25% drill cost carry on Selene well with
@shell
. Enterprise value of £13m is bonkers with a confirmed drill H1 22 full funded 55% GCOS.

has this not done a placing yet

what matters is drill results now

tbh any other company we would already have 5 bagged. bizarre and this has SHELL involved

I disagree with all of you, this was above 260p during the main 'pandemic' and they have failed to capitalise on it

most covid companies did well like avacta, genedrive, novacyte

this covid test kit company bloody went DOWN during this mess

#FPP #medicinalcannabis #spac #therapeutics #mainmarket #CBD #Wellness #shares

they have failed to capitalise on covid test kits when people like novacyte have made hundreds of millions from them

awful update.

bizarres hes going, probably a decent RTO here

Further under the Agreement, Alterola will endeavor to raise a total of at least $50,000,000 with $45,000,000 in net proceeds and Alterola will arrange an underwriting commitment of the first ($25,000,000 USD) to be funded at a price of not less than $1.00 per share within 45 days of execution of the Agreement.

Acquisition of ABTI Pharma



On January 19, 2021, we entered into an Stock Transfer Agreement (the “Agreement”) with ABTI Pharma Limited, a company registered in England and Wales (“ABTI Pharma”), pursuant to which the Company will acquire all of the outstanding shares of capital stock of ABTI Pharma from its shareholders in exchange for 600,000,000 shares of the Company pro rata to the ABTI Pharma shareholders. The shares have been issued in anticipation of the closing and the transaction will close upon the ABTI Pharma Limited Shares being transferred to the company which will occur upon the filing by the company of its outstanding annual report and form 10 k for 2019, and its quarterly reports for 2020, that are anticipated to be filed by March 30th2021.



Pursuant to the Agreement, from the date of execution, the Company will provide funding to ABTI Pharma to pay for operating expenses including salaries, office expenses and additional expenses or projects in the amount of US$500,000 within fifteen (15) days from closing the Agreement and shall fund an additional US $200,000 every 30 days thereafter until a total funding of US $1,100,000 has been delivered.

if it is this, then news must be imminent

its other peoples research, credit to them, I am just reposting here

https://seekingalpha.com/filing/5448182

hope this multibags, the plot thickens